American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Annexon
ANNX
$873M
| $57K | ﹤0.01% |
24,169
+5,041
| +26% | +$15.2K |
|
2702
Sensus Healthcare
SRTS
$51.5M
| $56.8K | ﹤0.01% |
20,516
| – | – |
|
|
TDAY
2703
USA Today Co
TDAY
$1.01B
| $56.4K | ﹤0.01% |
23,015
+12,862
| +127% | +$35.6K |
|
2704
Altimmune
ALT
$570M
| $55.3K | ﹤0.01% |
21,264
+10,093
| +90% | +$29K |
|
2705
Sight Sciences
SGHT
$456M
| $53.6K | ﹤0.01% |
15,908
+5,370
| +51% | +$35.3K |
|
2706
Codexis
CDXS
$175M
| $52.9K | ﹤0.01% |
28,001
+7,973
| +40% | +$18.6K |
|
2707
Purple Innovation
PRPL
$28.4M
| $51.7K | ﹤0.01% |
1,208
+429
| +55% | +$26.8K |
|
2708
BlackSky Technology
BKSY
$1.3B
| $51.5K | ﹤0.01% |
+5,499
| New | +$69.9K |
|
2709
Cue Biopharma
CUE
$128M
| $50K | ﹤0.01% |
725
+323
| +80% | +$31.5K |
|
2710
Traeger
COOK
$172M
| $49.9K | ﹤0.01% |
365
+135
| +59% | +$28.6K |
|
2711
ALX Oncology
ALXO
$278M
| $49.2K | ﹤0.01% |
+10,257
| New | +$55.7K |
|
2712
TScan Therapeutics
TCRX
$52.4M
| $49.2K | ﹤0.01% |
+19,212
| New | +$44.8K |
|
2713
Oramed Pharmaceuticals
ORMP
$178M
| $49K | ﹤0.01% |
18,764
+6,975
| +59% | +$22K |
|
2714
Quantum-Si Incorporated
QSI
$182M
| $46.8K | ﹤0.01% |
+28,169
| New | +$67.8K |
|
2715
Trevi Therapeutics
TRVI
$2.53B
| $46.7K | ﹤0.01% |
+21,427
| New | +$48.4K |
|
2716
Larimar Therapeutics
LRMR
$454M
| $46K | ﹤0.01% |
+11,646
| New | +$44K |
|
|
NOTV
2717
DELISTED
Inotiv
NOTV
| $45.9K | ﹤0.01% |
+14,904
| New | +$68.2K |
|
2718
Telos
TLS
$324M
| $45.7K | ﹤0.01% |
19,134
+7,985
| +72% | +$18.3K |
|
|
TUYA
2719
Tuya Inc
TUYA
$1.1B
| $45.2K | ﹤0.01% |
29,178
| – | – |
|
|
NIU
2720
Niu Technologies
NIU
$162M
| $43.1K | ﹤0.01% |
15,226
| – | – |
|
2721
BioAtla
BCAB
$5.61M
| $42.3K | ﹤0.01% |
498
+128
| +35% | +$16.3K |
|
2722
Rackspace Technology
RXT
$1.18B
| $40.7K | ﹤0.01% |
+17,338
| New | +$39.3K |
|
2723
China Automotive Systems
CAAS
$138M
| $40.2K | ﹤0.01% |
10,324
| – | – |
|
2724
Kodiak Sciences
KOD
$2.72B
| $37.2K | ﹤0.01% |
20,654
+6,013
| +41% | +$21.2K |
|
2725
Arbutus Biopharma
ABUS
$908M
| $36.1K | ﹤0.01% |
17,773
+7,113
| +67% | +$14.9K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.